IL115770A - Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections - Google Patents

Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections

Info

Publication number
IL115770A
IL115770A IL11577090A IL11577090A IL115770A IL 115770 A IL115770 A IL 115770A IL 11577090 A IL11577090 A IL 11577090A IL 11577090 A IL11577090 A IL 11577090A IL 115770 A IL115770 A IL 115770A
Authority
IL
Israel
Prior art keywords
tumours
inhibiting
growth
formula
preparation
Prior art date
Application number
IL11577090A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/339,343 external-priority patent/US5053394A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL115770A publication Critical patent/IL115770A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treating Waste Gases (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Lubricants (AREA)
  • Engine Equipment That Uses Special Cycles (AREA)
IL11577090A 1989-04-14 1990-03-13 Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections IL115770A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33932389A 1989-04-14 1989-04-14
US07/339,343 US5053394A (en) 1988-09-21 1989-04-14 Targeted forms of methyltrithio antitumor agents
IL9373390A IL93733A (en) 1989-04-14 1990-03-13 History of Dissolved Drug Sulphides Antibacterial and Antibacterial, Prepared from Compounds Containing Methyl-Thriteo Groups and Their Target Form

Publications (1)

Publication Number Publication Date
IL115770A true IL115770A (en) 1999-03-12

Family

ID=26991573

Family Applications (3)

Application Number Title Priority Date Filing Date
IL9373390A IL93733A (en) 1989-04-14 1990-03-13 History of Dissolved Drug Sulphides Antibacterial and Antibacterial, Prepared from Compounds Containing Methyl-Thriteo Groups and Their Target Form
IL11577090A IL115770A (en) 1989-04-14 1990-03-13 Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections
IL11577095A IL115770A0 (en) 1989-04-14 1995-10-25 Substituted disulfides of formula q-sp-ss-w their preparation and use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL9373390A IL93733A (en) 1989-04-14 1990-03-13 History of Dissolved Drug Sulphides Antibacterial and Antibacterial, Prepared from Compounds Containing Methyl-Thriteo Groups and Their Target Form

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL11577095A IL115770A0 (en) 1989-04-14 1995-10-25 Substituted disulfides of formula q-sp-ss-w their preparation and use

Country Status (16)

Country Link
EP (1) EP0392384B1 (fr)
JP (1) JP2951684B2 (fr)
CN (2) CN1046333A (fr)
AT (1) ATE163293T1 (fr)
AU (1) AU633069B2 (fr)
CZ (1) CZ293228B6 (fr)
DE (1) DE69032051T2 (fr)
DK (1) DK0392384T3 (fr)
ES (1) ES2112244T3 (fr)
FI (1) FI100105B (fr)
GR (1) GR3026177T3 (fr)
IL (3) IL93733A (fr)
NO (2) NO176717C (fr)
NZ (1) NZ233148A (fr)
PT (1) PT93716B (fr)
SK (1) SK284270B6 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
EP0342341A3 (fr) * 1988-05-17 1991-07-24 American Cyanamid Company Méthode pour la fabrication de l'antibiotique antitumoral LL-E33288 Gamma 2
GB9120467D0 (en) * 1991-09-26 1991-11-06 Celltech Ltd Anti-hmfg antibodies and process for their production
US6015562A (en) * 1992-09-22 2000-01-18 American Cyanamid Company Targeted forms of methyltrithio antitumor agents
US5773001A (en) * 1994-06-03 1998-06-30 American Cyanamid Company Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
US6441163B1 (en) * 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
SI3066074T1 (sl) * 2013-11-04 2020-03-31 Pfizer Inc. Intermediati in postopki za sintetizacijo derivatov kaliheamicina
MA45326A (fr) * 2015-10-20 2018-08-29 Genentech Inc Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
JP6917049B2 (ja) * 2017-02-22 2021-08-11 公立大学法人大阪 特定のサルファイド化合物に結合する抗体及びその使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE219096T1 (de) * 1987-01-30 2002-06-15 American Cyanamid Co Dihydroderivate der antibiotika vom typ ll-e33288
ES2059464T3 (es) * 1987-10-30 1994-11-16 American Cyanamid Co Formas especificamente dirigidas de agentes antitumorales de metiltritio.

Also Published As

Publication number Publication date
CN1109041C (zh) 2003-05-21
NO176717C (no) 1995-05-16
NO901655L (no) 1990-10-15
FI901866A0 (fi) 1990-04-12
JPH02292294A (ja) 1990-12-03
PT93716A (pt) 1990-11-20
NO177308B (no) 1995-05-15
EP0392384A3 (fr) 1991-11-06
IL93733A0 (en) 1990-12-23
DE69032051D1 (de) 1998-03-26
CN1110280A (zh) 1995-10-18
NZ233148A (en) 1996-02-27
NO932192L (no) 1990-10-15
JP2951684B2 (ja) 1999-09-20
PT93716B (pt) 1996-08-30
NO177308C (no) 1995-08-23
EP0392384A2 (fr) 1990-10-17
NO932192D0 (no) 1993-06-14
GR3026177T3 (en) 1998-05-29
AU633069B2 (en) 1993-01-21
ATE163293T1 (de) 1998-03-15
IL115770A0 (en) 1996-01-19
ES2112244T3 (es) 1998-04-01
NO176717B (no) 1995-02-06
SK284270B6 (sk) 2004-12-01
FI100105B (fi) 1997-09-30
SK188490A3 (en) 2000-08-16
DE69032051T2 (de) 1998-06-10
DK0392384T3 (da) 1998-03-16
CZ293228B6 (cs) 2004-03-17
AU5324190A (en) 1990-11-01
CN1046333A (zh) 1990-10-24
NO901655D0 (no) 1990-04-11
EP0392384B1 (fr) 1998-02-18
IL93733A (en) 1996-01-19
CZ188490A3 (cs) 2000-08-16

Similar Documents

Publication Publication Date Title
UA27105A1 (uk) О-метильhі похідhі азитроміциhу а, що мають аhтибактеріальhу активhість, спосіб їх отримаhhя та проміжhі сполуки
SG47520A1 (en) New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
PL250350A1 (en) Process for preparing 4"-epi-9-desketo-9a-methyl-9a-aza-9a-homoerythromycin a
HU9302329D0 (en) 7-(substituted)-9-|(substituted glycyl)-amino¨-6-desmethyl-6-desoxy-tetracyclines, pharmaceutical preparatives containing them and methods for producing them
IL115770A (en) Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections
HRP940251B1 (en) Process for the preparation of azithromycin dihydrochloride
FI103055B1 (fi) Menetelmä tiomarinolijohdannaisten valmistamiseksi
ES8205809A1 (es) Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas
EP0721985A4 (fr) Substance it-62-b et composition medicinale la contenant
ZA841850B (en) 2'-desoxyoxanosine,a process for the preparation thereof and its use as a medicament
ES2164013A1 (es) Glicosidos de n-acetil-6-o-(2,2-bis(hidroximetil)-3-hidroxipropil)-d-glucosamina, procedimiento de obtencion y uso en el tratamiento de tumores cerebrales.
CA2014486A1 (fr) Derives disulfidiques substitues, antitumoraux et antibacteriens, prepares a partir de composes ayant un groupement methyltrithio

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed